Save time and get answers to complex questions with AI chat
Diltiazem drug class?When will latisse patent expire?Excipients list used in dexamethasone creams?Drugpatentwatch skyrizi biologic patent analysis?What's the recommended schedule for lurbinectedin side effect checks?
See the DrugPatentWatch profile for simbrinza
Simbrinza is a fixed-dose eye drop that combines two active ingredients: - brimonidine - brinzolamide
The two ingredients target different parts of eye-pressure control. Brinzolamide reduces production of fluid in the eye, while brimonidine lowers eye pressure by decreasing fluid production and increasing outflow. The combination is used to treat elevated intraocular pressure (often in glaucoma or ocular hypertension).
No. Simbrinza is formulated as a single medication (a single eye-drop product) that delivers both drugs together in the same bottle, rather than requiring two separate prescriptions.
Other Questions About Simbrinza :